Medications

Plain-language guides to the antipsychotic medications used to treat schizophrenia, sourced from FDA labeling.

Schizophrenia Overview Psychosis & Episodes Medications Side Effects Famous People with Schizophrenia Patient Experiences CBT for Psychosis Hospitalisation & Crisis Lifestyle & Wellbeing For Families & Caregivers Engineering Schizophrenia Research

Clozapine vs olanzapine: when each one wins

Clozapine and olanzapine come from the same chemical family and share several side effects — but their indications, monitoring requirements, and place in treatment are very different.

Aripiprazole and weight: why it's gentler than most atypicals

Aripiprazole is among the most weight-neutral atypical antipsychotics — but 'weight-neutral' is not the same as 'no weight gain.' Here's the honest picture.

Alcohol and clozapine: why this combination is especially risky

Of all the antipsychotic-alcohol combinations clinicians worry about, clozapine sits at the top of the list. The reasons are pharmacological, not moralistic.

ECT (electroconvulsive therapy) for schizophrenia: when it's used

Electroconvulsive therapy is one of the oldest treatments in psychiatry and one of the most misunderstood. For specific situations in schizophrenia, the evidence is genuinely strong.

Aripiprazole lauroxil (Aristada): dosing intervals and initiation

Aristada gives clinicians the unusual flexibility of monthly, six-week, and eight-week injections — plus a one-day initiation that skips three weeks of oral overlap. Here's how it works.

Fluphenazine side effects: EPS and the first-generation profile

Fluphenazine works — but its high D2 affinity means movement side effects (EPS, akathisia, tardive dyskinesia) are common. Here is a practical guide to recognising and managing them.

Aripiprazole (Abilify): the partial dopamine agonist explained

Aripiprazole is the original partial dopamine agonist — neither a pure blocker nor a stimulator. The result is an antipsychotic with a distinctive side effect profile and a strong long-acting injectable presence.

Perphenazine side effects: the CATIE-trial first-generation

Perphenazine sits in the middle of the first-generation potency spectrum and held its own against newer drugs in the CATIE trial. Here is what its side effect profile actually looks like.

Aripiprazole side effects: akathisia, insomnia, and impulse-control issues

Aripiprazole tends to be lighter on weight gain and sedation but heavier on restlessness, sleep disruption, and a small but real risk of compulsive behaviours.

Alcohol and olanzapine: sedation, weight, and judgement

Olanzapine plus alcohol is one of the most common antipsychotic combinations clinicians actually see. The pharmacology is less dramatic than clozapine, but it isn't trivial.

TMS (transcranial magnetic stimulation) for schizophrenia

TMS is non-invasive and FDA-cleared for several conditions, but for schizophrenia it remains experimental. The most promising signals are in persistent voices and negative symptoms.

Fluphenazine decanoate: the first-generation LAI

Fluphenazine decanoate is one of the oldest long-acting injectables in continuous use — cheap, effective, and still a reasonable choice for the right patient.

Invega Sustenna: the monthly paliperidone injection

Invega Sustenna delivers a month of paliperidone in a single intramuscular injection — designed for people who struggle with daily oral dosing and for whom adherence is a major challenge.

Quetiapine (Seroquel): sedation, sleep, and broad clinical use

Quetiapine is one of the most widely used antipsychotics — heavily sedating, broadly licensed, and often prescribed off-label for sleep. The latter raises important issues.

Trifluoperazine side effects: EPS, sedation, the older typical

Trifluoperazine has been around for more than 60 years. Its side effect profile is dominated by movement effects but spares the metabolism — a trade-off that still appeals to some patients.

Therapeutic drug monitoring (TDM) of clozapine and norclozapine

Plasma level monitoring is one of the most useful tools in clozapine prescribing. Knowing the target range, when to draw, and what affects the number turns a confusing lab into a practical guide to dosing.

Cannabis and aripiprazole: pharmacology and clinical concerns

Aripiprazole is often described as a 'milder' antipsychotic, which can lead to assumptions that recreational substances are safer with it. The pharmacology says otherwise.

Risperidone vs paliperidone: parent drug vs active metabolite

Paliperidone is the active metabolite of risperidone. The two share most properties — but pharmacokinetics, prolactin effects, and long-acting injectable options separate them in practice.

Quetiapine and sleep: the off-label use, the doses, the trade-offs

Quetiapine is one of the most-prescribed off-label sleep aids in the United States. The reasons are understandable — and so are the concerns. Here's the honest picture.

Haloperidol (Haldol): the high-potency typical antipsychotic

Haloperidol is one of the oldest and most widely used antipsychotics in the world. It is potent, predictable, and affordable — but its side effect profile demands respect.

Quetiapine side effects: sedation, weight gain, and metabolic risks

Quetiapine's most common side effects are sedation and metabolic changes. Both are predictable, both are manageable — but only with proactive monitoring and honest conversations.

Haloperidol decanoate: dosing, side effects, and monitoring

Haloperidol decanoate has been a workhorse LAI for decades — given monthly, inexpensive, and effective at preventing relapse. The tradeoff is a higher movement-side-effect profile.

Thiothixene side effects: an older first-generation profile

Thiothixene is a chemically distinctive but pharmacologically familiar first-generation antipsychotic. Here is what to expect from its side effect profile and how to manage it.

Ziprasidone (Geodon): the weight-neutral atypical with a food requirement

Ziprasidone is among the most weight-neutral atypicals — but it requires food for absorption and demands attention to cardiac safety.

Antipsychotics and antibiotics: what to watch for

Most antibiotics combine fine with antipsychotics — but a few common ones can sharply raise drug levels, prolong QT, or cause unique problems with clozapine.

Stimulants (Adderall, Ritalin) and antipsychotics

Antipsychotics block dopamine. Stimulants release it. Combining them is not always wrong — but it requires a clear clinical reason and careful monitoring.

Psilocybin and psychosis: why people with schizophrenia are excluded from trials

Psilocybin is being studied for depression, addiction, end-of-life distress, and more. Every major trial excludes people with personal or family history of psychosis — here's why that matters.

Aripiprazole vs brexpiprazole: same family, different feel

Brexpiprazole was designed as a less activating, less akathisia-prone cousin of aripiprazole. The pharmacology supports the idea — and the clinical evidence partly does too.

Metformin for antipsychotic-induced weight gain

Metformin is now considered first-line pharmacological treatment for antipsychotic-induced weight gain — modest in effect size, but better-evidenced than any other option.

Chlorpromazine (Thorazine): the first antipsychotic ever discovered

Chlorpromazine was the first antipsychotic ever discovered and arguably the medication that emptied the asylums. It is still in use today — but its role has narrowed.